Beta-adrenergic receptors are critical for weight loss but not for other metabolic adaptations to the consumption of a ketogenic diet in male mice

Autor: Kamal Rahmouni, Eleftheria Maratos-Flier, Eleen Zarebidaki, Jeffrey S. Flier, Theodore I. Cisu, Ngoc Ly T. Nguyen, Bhavna N. Desai, ffolliott M. Fisher, Alan J. Fowler, Donald A. Morgan, Nicholas Douris, Timothy J. Bartness
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
SNS
sympathetic nervous system

Male
Weight loss
FGF21
Sympathetic Nervous System
medicine.medical_treatment
FGF21
fibroblast growth factor 21

Mice
KD
ketogenic diet

Brown adipose tissue
SNA
sympathetic nerve activity

IWAT
inguinal white adipose tissue

β-less
lacking β1
β2
β3 adrenergic receptors

Receptor
Ketogenic diet
Adaptation
Physiological

Receptors
Adrenergic

medicine.anatomical_structure
Liver
Mice
Inbred DBA

Original Article
IP
intraperitoneal

Diet
Ketogenic

lcsh:Internal medicine
medicine.medical_specialty
Adrenergic receptor
Alpha (ethology)
Biology
SEM
standard error of the mean

03 medical and health sciences
Internal medicine
UCP1
uncoupling protein 1

medicine
Animals
β-Adrenergic receptors
lcsh:RC31-1245
Molecular Biology
ITT
insulin tolerance test

PPARα
peroxisome proliferator-activated receptor alpha

Insulin
EE
energy expenditure

Cell Biology
medicine.disease
BAT
brown adipose tissue

Fibroblast Growth Factors
Mice
Inbred C57BL

030104 developmental biology
Endocrinology
Ketosis
Zdroj: Molecular Metabolism
Molecular Metabolism, Vol 6, Iss 8, Pp 854-862 (2017)
ISSN: 2212-8778
Popis: Objective We have previously shown that the consumption of a low-carbohydrate ketogenic diet (KD) by mice leads to a distinct physiologic state associated with weight loss, increased metabolic rate, and improved insulin sensitivity [1]. Furthermore, we identified fibroblast growth factor 21 (FGF21) as a necessary mediator of the changes, as mice lacking FGF21 fed KD gain rather than lose weight [2]. FGF21 activates the sympathetic nervous system (SNS) [3], which is a key regulator of metabolic rate. Thus, we considered that the SNS may play a role in mediating the metabolic adaption to ketosis. Methods To test this hypothesis, we measured the response of mice lacking all three β-adrenergic receptors (β-less mice) to KD feeding. Results In contrast to wild-type (WT) controls, β-less mice gained weight, increased adipose tissue depots mass, and did not increase energy expenditure when consuming KD. Remarkably, despite weight-gain, β-less mice were insulin sensitive. KD-induced changes in hepatic gene expression of β-less mice were similar to those seen in WT controls eating KD. Expression of FGF21 mRNA rose over 60-fold in both WT and β-less mice fed KD, and corresponding circulating FGF21 levels were 12.5 ng/ml in KD-fed wild type controls and 35.5 ng/ml in KD-fed β-less mice. Conclusions The response of β-less mice distinguishes at least two distinct categories of physiologic effects in mice consuming KD. In the liver, KD regulates peroxisome proliferator-activated receptor alpha (PPARα)-dependent pathways through an action of FGF21 independent of the SNS and beta-adrenergic receptors. In sharp contrast, induction of interscapular brown adipose tissue (BAT) and increased energy expenditure absolutely require SNS signals involving action on one or more β-adrenergic receptors. In this way, the key metabolic actions of FGF21 in response to KD have diverse effector mechanisms.
Highlights • Ketogenic diets lead to rapid increases in energy expenditure via increased sympathetic outflow to BAT. Long term the diet leads to weight loss. • β-adrenergic receptors mediate these effects; in mice lacking all three β-receptors the effects of the ketogenic diet are not observed. • Browning of subcutaneous fat by the diet is partially activated by presumed peripheral mechanisms in the absence of β-adrenergic receptors. • Sympathetic nervous system activity not required for improved insulin sensitivity and activation of fatty acid oxidation in the liver.
Databáze: OpenAIRE